Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 58 (RPL21P58)

Target
RPL21P58
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 58 (RPL21P58) is a human processed pseudogene related to the RPL21 gene, encoding 60S ribosomal protein L21 in its functional form. RPL21P58 itself does not produce a protein and currently has no known biological function, therapeutic relevance, or disease association. While some ribosomal protein pseudogenes have been linked to disease states or regulatory functions as non-coding RNAs, there is no such information specifically for RPL21P58[1][5][6]. As a pseudogene, it is not a validated target for pharmacological intervention and is not referenced as a biomarker or target in the clinical or scientific literature. RPL21P58 is a human pseudogene corresponding to ribosomal protein L21, not a protein-coding gene, enzyme, receptor, or therapeutic target. If you are seeking information about a functional ribosomal protein with therapeutic or biological importance, refer to RPL21, not its pseudogene[1][7].

Other names
RPL21_22_606RPL21P58

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 58 (RPL21P58).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 58 (RPL21P58).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call